Within the disordered tangles of Tau is a proline-rich region, which is selectively targeted by the SH3 domain of BIN1, a known genetic factor for Alzheimer disease, and may hold the key to understanding the disorder and treatment strategies. Hyperphosphorylation of Tau is known to disrupt complex formation, providing researchers with excellent preventative or remediative targets. This work compiles an extensive (>60 μs) collection of all-atomistic molecular dynamics simulations of the Tau(210-240) fragment, representing the majority of the P2 subdomain of the proline-rich region, benchmarking various force fields, phosphorylations, and modifications against experimental NMR chemical shifts and spin-spin coupling for comparison. Additionally, several simulations of the binding complex were analyzed for their binding energies by MMGBSA calculations and computational alanine scanning to pinpoint the exact residues involved and the disruptions caused by the phosphate group. We noted that the additional charges decrease salt bridges formed by positive residues in Tau, particularly on R221, and negative residues in BIN1 by up to 32%, and a strong preference in Tau, particularly in the latter half, for contact toward the distal and n-Src loops instead of residues in the RT-Src loop.

CEITEC Masaryk University Brno Czech Republic; Department of Chemistry Faculty of Science Masaryk University Brno Czech Republic; Consiglio Nazionale delle Ricerche Trieste Italy

Faculty of Pharmacy in Hradec Králové Charles University Akademika Heyrovského 1203 8 Hradec Králové Czech Republic

Zobrazit více v PubMed

Zhang X., Wang J., et al. Ye K. Tau in Neurodegenerative Diseases: Molecular Mechanisms, Biomarkers, and Therapeutic Strategies. Transl. Neurodegener. 2024;13:40. PubMed PMC

Pîrşcoveanu D.F.V., Pirici I., et al. Pîrşcoveanu M. Tau protein in Neurodegenerative Diseases - a Review. Rom. J. Morphol. Embryol. 2017;58:1141–1150. PubMed

Kolarova M., García-Sierra F., et al. Ripova D. Structure and Pathology of Tau Protein in Alzheimer Disease. Int. J. Alzheimers Dis. 2012;2012:1–13. PubMed PMC

Gustke N., Trinczek B., et al. Mandelkow E. Domains of tau Protein and Interactions with Microtubules. Biochemistry. 1994;33:9511–9522. PubMed

Sallaberry C.A., Voss B.J., et al. Vander Zanden C.M. Tau and Membranes: Interactions That Promote Folding and Condensation. Front. Cell Dev. Biol. 2021;9 PubMed PMC

Goedert M., Spillantini M.G., et al. Crowther R.A. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer’s disease. Neuron. 1989;3:519–526. PubMed

Sillen A., Barbier P., et al. Lippens G. NMR Investigation of the Interaction between the Neuronal Protein Tau and the Microtubules. Biochemistry. 2007;46:3055–3064. PubMed

Sottejeau Y., Bretteville A., et al. Lambert J.-C. Tau phosphorylation regulates the interaction between BIN1’s SH3 domain and Tau’s proline-rich domain. Acta Neuropathol. Commun. 2015;3 PubMed PMC

Malki I., Cantrelle F.X., et al. Landrieu I. Regulation of the interaction between the neuronal BIN1 isoform 1 and Tau proteins – role of the SH3 domain. FEBS J. 2017;284:3218–3229. PubMed

Roth J.R., Rush T., et al. Roberson E.D. Development of small-molecule Tau-SH3 interaction inhibitors that prevent amyloid-β toxicity and network hyperexcitability. Neurotherapeutics. 2024;21 PubMed PMC

Lasorsa A., Malki I., et al. Landrieu I. Structural Basis of Tau Interaction With BIN1 and Regulation by Tau Phosphorylation. Front. Mol. Neurosci. 2018;11 PubMed PMC

Lasorsa A., Bera K., et al. Landrieu I. Conformation and Affinity Modulations by Multiple Phosphorylation Occurring in the BIN1 SH3 Domain Binding Site of the Tau Protein Proline-Rich Region. Biochemistry. 2023;62:1631–1642. PubMed

Santiago J., Pocevičiūtė D., et al. Wennström M. Retinal tau phosphorylation in Alzheimer’s disease: A mass spectrometry study. Neurobiol. Dis. 2025;215 PubMed

Suárez-Calvet M., Karikari T.K., et al. Vilor-Tejedor N. Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in A βpathology are detected. EMBO Mol. Med. 2020;12 PubMed PMC

Sibille N., Huvent I., et al. Landrieu I. Structural Characterization by Nuclear Magnetic Resonance of the Impact of Phosphorylation in the Proline-Rich Region of the Disordered Tau Protein. Proteins. 2012;80:454–462. PubMed

Hanwell M.D., Curtis D.E., et al. Hutchison G.R. Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. J. Cheminf. 2012;4:17. PubMed PMC

Jumper J., Evans R., et al. Hassabis D. Highly Accurate Protein Structure Prediction with AlphaFold. Nature. 2021;596:583–589. PubMed PMC

Shen Y., Bax A. SPARTA+: a Modest Improvement in Empirical NMR Chemical Shift Prediction by Means of an Artificial Neural Network. J. Biomol. NMR. 2010;48:13–22. PubMed PMC

Zweckstetter M., Siegert A. 2021. Biological Magnetic Resonance Data Bank Entry 50701.https://bmrb.io/data_library/summary/index.php?bmrbId=50701

Narayanan R.L., Dürr U.H.N., et al. Zweckstetter M. Automatic Assignment of the Intrinsically Disordered Protein Tau with 441-Residues. J. Am. Chem. Soc. 2010;132:11906–11907. PubMed

Verdegem D., Sibille N., et al. Huvent I. 2011. Biological Magnetic Resonance Data Bank. Entry 17945.https://bmrb.io/data_library/summary/index.php?bmrbId=50701

Crha R., Kozelekova A., et al. Hritz J. 2024. Biological Magnetic Resonance Data Bank Entry 52418.https://bmrb.io/data_library/summary/index.php?bmrbId=52418

Crha R., Kozeleková A., et al. Hritz J. Hiding in Plain Sight: Complex Interaction Patterns between Tau and 14-3-3ζ Protein Variants. Int. J. Biol. Macromol. 2024;266 PubMed

Gaffour A., Bakker M., et al. Landrieu I. 2025. Zenodo (EU Open Research Repository) DOI

Karplus M. Contact Electron-Spin Coupling of Nuclear Magnetic Moments. J. Chem. Phys. 1959;30:11–15.

Karplus M. Vicinal Proton Coupling in Nuclear Magnetic Resonance. J. Am. Chem. Soc. 1963;85:2870–2871.

Wang B., He X., Merz K.M. Quantum Mechanical Study of Vicinal J Spin-Spin Coupling Constants for the Protein Backbone. J. Chem. Theor. Comput. 2013;9:4653–4659. PubMed

Abraham M.J., Murtola T., et al. Lindahl E. GROMACS: High Performance Molecular Simulations Through Multi-Level Parallelism from Laptops to Supercomputers. SoftwareX. 2015;1–2:19–25.

McGibbon R.T., Beauchamp K.A., et al. Pande V.S. MDTraj: A Modern Open Library for the Analysis of Molecular Dynamics Trajectories. Biophys. J. 2015;109:1528–1532. PubMed PMC

Gorelov S., Titov A., et al. Shvetsov A. DSSP in GROMACS: Tool for Defining Secondary Structures of Proteins in Trajectories. J. Chem. Inf. Model. 2024;64:3593–3598. PubMed

Schrödinger, LLC, 2015. The PyMOL Molecular Graphics System, Version 1.8 Date-Added: 2010-08-19 17:29:55 -0400, Date-Modified: 2015-12-22 18:04:08 -0400.

Valdés-Tresanco M.S., Valdés-Tresanco M.E., et al. Moreno E. gmx_MMPBSA: A New Tool to Perform End-State Free Energy Calculations with GROMACS. J. Chem. Theor. Comput. 2021;17:6281–6291. PubMed

Krïger D.M., Gohlke H. DrugScorePPI webserver: fast and accurate in silico alanine scanning for scoring protein–protein interactions. Nucleic Acids Res. 2010;38:W480–W486. PubMed PMC

Bakker M.J., Sørensen H.V., Skepö M. Exploring the Role of Globular Domain Locations on an Intrinsically Disordered Region of p53: A Molecular Dynamics Investigation. J. Chem. Theor. Comput. 2024;20:1423–1433. PubMed PMC